About AEI My AEI Support AEI Contact AEI
Home Events Books Short Publications Research Areas Scholars & Fellows


Search


FindAdvanced Search

Browse all short publications by:
- Date
- Subject
- Author
- Type
- Title

SHORT PUBLICATIONS
AEI Newsletter
AEI.org Exclusives
The American
Press Releases
Outlook Series
On the Issues
Papers and Studies
AEI Working Paper Series
Government Testimony
Speeches
Book Reviews
AEI Policy Series
The War on Terror

E-NEWSLETTERS
Enter e-mail:
 

Home >  Short Publications >  China's Dangerous Drug Exports
China's Dangerous Drug Exports
Print Mail
By Roger Bate
Posted: Thursday, September 18, 2008
ARTICLES
Economic Affairs  
Publication Date: September 18, 2008

 
Resident Fellow
Roger Bate
 
The recent furore over contaminated heparin, a blood-thinning drug, that killed at least 81 Americans, was just the latest in a string of medical problems traced back to Chinese food and pharmaceutical exports. Heparin was exported from Scientific Protein Laboratories LLC, based in Changzhou, China. Raw heparin is normally sourced from the intestines of pigs, but the US Food and Drug Administration found a contaminant that comes from pig cartilage. The contaminant--oversulphated-chondroitin sulphate--is much cheaper, but isn't approved for medical use because it can cause severe allergic reactions in humans. Prior cases of melaminecontaminated products follow a similar pattern. Cheaper contaminants are added, with Chinese authorities unable or unwilling to stop it. Why did Beijing not stop them?. . . .

Download file Click here to view the full text of this article as an Adobe Acrobat PDF.

Roger Bate is resident fellow at AEI.

Related Links
Related article on China's bad medicine by Bate
Related article on counterfeit drugs by Bate
Related article on drugs and China by Bate
AEI Print Index No. 23494


Also by Roger Bate
Recent Articles
Fighting Fake Drugs in India
The Wrong Message in a Bottle
Zimbabwe Is on the Ropes
Latest Book
Making a Killing
The Deadly Implications of the Counterfeit Drug Trade
Middle Eastern Outlook

Middle Eastern OutlookIn the latest edition of Middle Eastern Outlook, Michael Rubin questions whether the United States can really deter or contain a nuclear weapons-capable Iran.


Receive Printed Copies of Publications and Support AEI
Would you like us to mail you printed copies of publications in addition to your personalized My AEI e-mail updates? Consider enrolling in the AEI Associates Program with a tax-deductible contribution. As an associate, you will receive print versions of many AEI publications, including the AEI Newsletter, On the Issues articles, and The American.